Pharmallama on Shark Tank India episode, founder name, deal, investors, valuation, revenue, net worth

Pharmallama is a drug management company, find out more about the company and its experience on Shark Tank India season 2, know its founder name and valuation

Shark Tank India’s second season has shown tremendous growth in popularity among Indian viewers. People from all various age groups are drawn to this business-related show.

The show’s unique ways of entertaining viewers and grabbing their attention by delivering captivating pitches for various goods and services are some of the primary aspects that contribute to its appeal.

However, only a few pitches stand out compared to others, and the bulk of those that do are those that land an all-shark agreement. A comparable business that is involved with the pharmaceutical sector was recently highlighted in the program.

Pharmallama on Shark Tank India episode, founder name, deal, investors, valuation, revenue, net worth in 2023

The business named Pharmallama has been in the news since it grabbed the all-shark deal on the show. So, let’s find out everything about it:

More about Pharmallama

Pharmallama Company offers cutting-edge drug management solutions by using its own technology to pack medication into individualized sachets marked with the patient’s name, dose, day, and time. This service is especially beneficial for older individuals who have trouble managing their medications.

In June 2020, Achintya Dayal, Arjun Raghunandan, and Deepesh Rajpal launched the business. Moreover, Dayal and Raghunandan are the founders of the travel technology company Kiplist, which creates SaaS products for the hospitality sector.

To use Pharmallama’s services, patients need only upload their prescriptions to the Pharmallama app. The pharmacists’ group next evaluates the prescription and separates the drug into time- and date-labeled individual sachets. The 30-day supply of sachets is then placed in an accessible dispenser and delivered to the customer’s door. Customers can contact pharmacists via phone or email with any questions.

According to the company’s financial data, each order has a ₹20 packaging fee, a ₹900 client acquisition fee, and a ₹1400 average order value. They have a remarkable 91% retention rate.

Its experience on Shark Tank India 2

To Pharmallama company, shark Anupam Mittal first offered to invest ₹1 crore for 2.22% equity, valuing the company at ₹45 crores. Later, the business was also presented with an all-shark offer of ₹2 crores for 5% equity, valuing the company at ₹40 crores.

The business pitcher countered with an offer of ₹2 crores for 4% equity, valuing the company at ₹50 crores. However, since the sharks couldn’t come to an agreement, the final deal was made on the All Shark Offer, where the founders received ₹2 crores for 5% equity in their business.

ALSO READ: What is the Wachtell US Law Firm, its salary, fees, owner, clients and cases as Gautam Adani hires it vs Hindenburg Research